期刊文献+

新型冠状病毒肺炎合并肝损伤研究现状与挑战分析 被引量:1

The analysis of present researches and challenges of COVID-19 with liver injury
下载PDF
导出
摘要 新型冠状病毒肺炎(COVID-19)作为一种发病率高、传染性强、病情变化快的公共卫生事件,发病以来受到国内外高度关注。随着其临床特征及发病机制的研究进展,该病呼吸系统以外症状受到越来越多的重视。肝脏不仅是机体能量代谢的场所,也是重要免疫器官,是COVID-19疾病进程中受累的重要脏器之一。本文就COVID-19合并肝损伤研究现状及面临挑战作一探讨,旨在提高疫情防控中对该病的认识,减少COVID-19合并肝损伤的发生,降低不良结局的风险,为优化临床诊治方案及拓展研究思路提供一定的参考。 As a public health event,Corona Virus Disease 2019(COVID-19)is highly concerned at home and abroad since its onset because it has the characteristics of high incidence,strong contagion,and rapid changes.With the research progress of its clinical characteristics and pathogenesis,more and more attention has been paid to the symptoms outside the respiratory system.We know that liver is not only the site of energy metabolism,but also an important immune organ.In addition,it is one of the important damaged organs involved in the process of COVID-19.This article analyzed the present researches and challenges of COVID-19 with liver injury research in order to enhance the acknowledgement of this disease in epidemic prevention and control.It will help to decrease the incidence of COVID-19 with liver injury and reduce the risk of adverse outcomes,in order to provide reference for optimizing the clinical decision about diagnosis and treatment and expand the research ideals.
作者 贺娜 冯巩 姚诚子 申娜宁 秦洁 康改玲 HE Na;FENG Gong;YAO Chengzi;SHEN Naning;QIN Jie;KANG Gailing(Department of Gastroenterology,the First Affiliated Hospital of Xi’an Medical University,Xi’an 710077;Institute of General Practice,Xi’an Medical University,China)
出处 《胃肠病学和肝病学杂志》 CAS 2020年第4期397-400,共4页 Chinese Journal of Gastroenterology and Hepatology
基金 2020陕西省高等教育学会“疫情防控专项研究课题”(XGH20043)。
关键词 新型冠状病毒肺炎 肝损伤 临床特征 发病机制 防治策略 Corona Virus Disease 2019 Liver injury Clinical characteristics Pathogenesis Prevention and treatment strategy
  • 相关文献

参考文献5

二级参考文献56

  • 1Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med, 2003, 348: 1986-1994.
  • 2Zimmerman JE, Knaus WA, Sun X, et al. Severity stratification and outcome prediction for multisystem organ failure and dysfunction.World J Surg, 1996, 20: 401-405.
  • 3Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet, 2003, 361:1319-1325.
  • 4Oba Y. The use of corticosteroids in SARS. N Engl J Med, 2003,348: 2034-2035.
  • 5Kalden J. What is inflammation? Eur Heart J, 1987,8(suppl J): 1-5.
  • 6Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature,2007,449(7164):819-826.
  • 7Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol,2008,180(9):5771-5777.
  • 8Chen GY, Nufiez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol,2010,10(12):826-837.
  • 9Speyer CL, Ward PA. Role of endothelial chemokines and their receptors during inflammation. J Invest Surg,2011,24(1): 18-27.
  • 10Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci,2008,9(1):46-56.

共引文献531

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部